An Urgent Need: More R&D

The Ebola outbreak illustrates a hard truth, asserts Mel Spigelman, president and CEO of TB Alliance: The US must support more global health research and development in infectious diseases and other health threats.

It's a position echoed in a new Global Health Technologies Coalition report, which reveals that taxpayer funding for global health research has declined or remained stagnant since 2009. In a Washington Post essay, Spigelman says that inadequate funding is also partly to blame for the proliferation of multidrug-resistant TB.

"When the next Ebola-like emergency arrives—or in the case of drug-resistant TB, continues to spread—there will be widespread indignation that we failed to anticipate the threat and did not prepare accordingly," writes Spigelman.

The Washington Post

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top